The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Edwards Lifesciences Corp

NYSE: EW
Last

(U.S.) $111.34

Today's change+0.14 +0.13%
Updated October 19 11:28 AM EDT. Delayed by at least 15 minutes.
 

Edwards Lifesciences Corp

NYSE: EW
Last

(U.S.) $111.34

Today's change+0.14 +0.13%
Updated October 19 11:28 AM EDT. Delayed by at least 15 minutes.

Edwards Lifesciences Corp up (U.S.)$0.14

Edwards Lifesciences Corp is up today by (U.S.)$0.14 or 0.13% to (U.S.)$111.34. Over the last five days, shares have gained 1.03% and 18.83% year to date. Shares have underperformed the S&P 500 by 24.57% during the last year.

Key company metrics

  • Open(U.S.) $111.46
  • Previous close(U.S.) $111.20
  • High(U.S.) $111.67
  • Low(U.S.) $110.84
  • Bid / Ask(U.S.) $111.28 / (U.S.) $111.34
  • YTD % change+18.83%
  • Volume414,724
  • Average volume (10-day)1,073,097
  • Average volume (1-month)1,204,615
  • Average volume (3-month)1,217,927
  • 52-week range(U.S.) $81.12 to (U.S.) $121.45
  • Beta0.49
  • Trailing P/E33.72×
  • P/E 1 year forward29.43×
  • Forward PEG1.79×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $3.30
Updated October 19 11:28 AM EDT. Delayed by at least 15 minutes.
S&P TSX0.21%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue842884768739
Total other revenue--------
Total revenue842884768739
Gross profit631668555538
Total cost of revenue211216213201
Total operating expense636590567554
Selling / general / administrative244230234230
Research & development134129115113
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)391057
Other operating expenses, total2-403
Operating income206294200185
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax206294200185
Income after tax186230159141
Income tax, total20634244
Net income186230159141
Total adjustments to net income--------
Net income before extra. items186230159141
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items186230159141
Inc. avail. to common incl. extra. items186230159141
Diluted net income186230159141
Dilution adjustment------0
Diluted weighted average shares216216218218
Diluted EPS excluding extraordinary itemsvalue per share0.861.060.730.65
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share1.031.100.740.67